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0012-16journal homepage: www.elsevier.com/locate/developmentalbiologyPrefaceModeling human development and disease in XenopusXenopus has long been a powerful and important animal model
for investigating fundamental questions in developmental and cell
biology due to the unique experimental advantages of this system.
Not surprisingly, studies in Xenopus are increasingly also making
important contributions to our understanding of human health
and disease. Xenopus embryos develop rapidly and have broad
strengths as an experimental platform. Importantly, Xenopus also
bridges the gap between more costly and less tractable mamma-
lian models and the evolutionarily more distant zebraﬁsh model,
and as such it is uniquely positioned to inform conserved biolo-
gical processes relevant to human health. This Special Issue
highlights a number of these research areas with reviews and
original research papers.
This is an exciting and transformative time in biomedical re-
search. Rapid advances in proteomics, genomics and genome
editing are enabling analyses of development, cellular function
and disease on an unprecedented scale. While Xenopus has fre-
quently been the model of choice for vertebrate studies requiring
biochemical approaches and mechanistic depth, it is also ideally
suited to systems-level analysis, functional genomics and human
disease modeling. Such studies have been facilitated by the de-
velopment of important resources supporting work in this model,
including the establishment of the National Xenopus Resource
(NXR) in Woods Hole, MA (to complement the European Xenopus
Resource Center and the National BioResource Project of Japan),
the increasingly well annotated genomes for both Xenopus laevis
and Xenopus tropicalis, and the continued development of the
online system resource and bioinformatics database Xenbase
(http://xenbase.org), including the addition of invaluable tran-
scriptome and proteomic datasets. Notably, in this issue Grant
et al. report the establishment of an important new resource, the
Xenopus ORFeome.
For more than 50 years Xenopus has been a cornerstone of
discovery driven research seeking to answer fundamental ques-
tions in cell and developmental biology, molecular biology, neu-
robiology, and physiology. The importance of such basic sciencex.doi.org/10.1016/j.ydbio.2015.11.019
06/& 2015 Published by Elsevier Inc.studies cannot be overstated. An excellent example of this is the
pioneering work of Sir John Gurdon, who was awarded the 2012
Nobel Prize in Physiology or Medicine for his discovery that ma-
ture Xenopus intestinal cells could be reprogrammed to plur-
ipotency following transplantation of the nucleus into a fertilized
egg, work aimed at demonstrating the constancy of the genome.
Notably, this work was not translational in intent, but instead is an
illustrative example of how basic science for the sake of basic
science frequently has clear translational implications. Gurdon’s
ﬁndings ultimately led to Somatic Cell Nuclear Transfer (SCNT)
technologies and the creation of induced pluripotent stem cells
(iPSCs), which together have revolutionized biomedical research
and spawned the ﬁeld of regenerative medicine.
Looking forward, it is clear that Xenopus will continue to drive
the important basic science advances that derive from curiosity/
discovery driven research, and that these advances will in turn
inform our understanding of human disease and create avenues
for therapeutic intervention. As this Special Issue highlights,
however, Xenopus is increasingly powering more applied studies
directly aimed at modeling human diseases and developmental
disorders, and a real strength of the system is the ease of making
humanized mutations for rapid functional analysis. Such studies
will only increase the pace of biological discovery using Xenopus
and its continued importance as a model system.Carole LaBonne n
Dept. of Molecular Biosciences; and Robert H. Lurie Comprehensive
Cancer Center, Northwestern University, Evanston, Il 60208
E-mail address: clabonne@northwestern.edu
Aaron M. Zorn
Division of Developmental Biology, Perinatal Institute, Cincinnati
Children's Hospital, and the Department of Pediatrics, College of
Medicine University of Cincinnati, Cincinnati, Ohion Corresponding author.
